MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2025 Innovation Award for Remote Cardiac Diagnostics
HeartBeam (NASDAQ: BEAT), a medical technology company advancing personalized cardiac care, has received the Innovation Award in Remote Cardiac Diagnostics from the 2025 Medical Device Network Excellence Awards. The honor recognizes HeartBeam’s FDA-cleared 3D ECG…
-
Safe Pro Group Inc. (NASDAQ: SPAI) Earns Buy Rating, $8 Price Target from Litchfield Hills
Safe Pro Group (NASDAQ: SPAI), an emerging provider of AI-powered security and threat detection solutions, has received a Buy rating from Litchfield Hills Research upon coverage initiation on July 17, with the firm setting an…
-
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Secures EU Patent for AI-Designed Cancer Drug LP-284
Lantern Pharma (NASDAQ: LTRN) announced the European Patent Office has issued a notice of allowance for a composition of matter patent covering LP-284, a clinical-stage drug candidate for relapsed or refractory non-Hodgkin’s lymphoma. The patent,…
-
MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Integrates AI Object Detection with U.S. Army Recon Drones
Safe Pro Group (NASDAQ: SPAI) has integrated its patented AI object detection models into drone platforms selected for the U.S. Army’s Short Range Reconnaissance Program of Record, aiming to enhance explosive threat detection and ISR…
-
MissionIRNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Leveraging Crypto to Bridge New World and Classic Industry
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada…
-
MissionIRNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Charts Dual-Path for NRX-100
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, is accelerating its push toward regulatory approval of NRX-100, a preservative-free intravenous ketamine formulation. “The company recently filed an…
-
D-Wave Quantum Inc. (NYSE: QBTS) Secures $400 Million in Equity Offering, Eyes Acquisitions and Expansion
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has completed sales of $400 million in gross proceeds of its common stock in an at-the-market equity (“ATM”) offering, a move…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Sets Key Dates for 25% Preferred Stock Dividend
Nutriband (NASDAQ: NTRB) is reminding shareholders of its upcoming 25% preferred stock dividend. Shareholders of record as of July 25, 2025, will receive one preferred share for every four common shares held, with the dividend…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharma company focused on treating brain and CNS cancers, will implement a 1-for-12 reverse stock split effective July 22, 2025. Its common stock will continue trading under the symbol CNSP…
-
Soligenix Inc. (NASDAQ: SNGX) Reports Strong Results in ‘Real-World’ Trial
Soligenix (NASDAQ: SNGX) is reporting encouraging interim outcomes from the ongoing investigator-initiated study (“IIS”) of its HyBryte(TM) (synthetic hypericin) program, under the direction of Ellen Kim, MD, director of the Penn Cutaneous Lymphoma Program. Kim is…
-
Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Key Part of Five-Step Blueprint for a Balanced Rare-Earth Supply Chain
The tariff war between the United States and other countries, particularly China, has created a greater awareness of the tenuous U.S. position in terms of its reliance on China for essential materials for key products.…
-
MissionIRNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, is executing a dual growth strategy focused on expanding its national network of mental health clinics through its subsidiary, HOPE Therapeutics, and advancing its proprietary NMDA-based therapies…
-
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Aligns Strategy as North American Energy Policy Shifts
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Highlights August as Key Window for Commercial EV Incentives Through Bollinger Motors
Mullen Automotive (NASDAQ: MULN), through its subsidiary Bollinger Motors, announced that August will present a prime opportunity to purchase commercial EVs as New York’s Truck Voucher Incentive Program (NYTVIP) is set to be replenished. The…
-
MissionIRNewsBreaks – Zacks Research Releases Updated Report as Soligenix Inc. (NASDAQ: SNGX) Eyes Upcoming ‘Key Catalysts’
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research report that presented a favorable analysis, noting that the company is anticipating a number of key…
-
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Launches AI Module to Accelerate Development of Targeted Cancer Combination Therapies
Lantern Pharma (NASDAQ: LTRN), an AI-driven oncology drug developer, announced the launch of a new AI-powered module within its RADR(R) platform to predict the efficacy of combination therapies involving DNA-damaging agents (DDAs) and DNA damage…
-
Safe Pro Group Inc. (NASDAQ: SPAI) to Benefit from $33 Billion US Defense Bill Targeting AI and Drone Innovation
With the U.S. government committing over $33 billion to artificial intelligence and drone technology through the newly enacted One Big Beautiful Bill Act (“OBBBA”), the defense landscape is poised for a rapid evolution, and Safe Pro…
-
MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Eyes Growth as ‘Fast Motion’ Gains Traction
Newton Golf Company (NASDAQ: NWTG) is realizing triple-figure revenue growth after the launch of its newest shaft family. The company’s CEO Greg Campbell was quoted in a recent article that highlights the growing interest in Fast…
-
MissionIRNewsBreaks – FAVO Capital Inc.’s (FAVO) Multi-Prong Digital Strategy Drives SMB Growth
FAVO Capital (OTC: FAVO) is positioned as inflationary pressures and elevated interest rates strain traditional financing channels and small and medium-sized businesses (“SMBs”) increasingly seek alternative funding sources to maintain liquidity and drive growth. The company…
-
AI Drones Dropping Mines As Minefields Return to Europe, Safe Pro Group Inc. (NASDAQ: SPAI) Delivers Scalable AI Drone Tech to Detect the Old and New Threat
The Cold War-era threat of land mines is resurfacing in Europe with a new layer, dropping mines from AI Drones. According to a recent New York Times report, five NATO-aligned countries – Poland, Finland, and the three…
-
MissionIRNewsBreaks – Rare Biotech Story: Nutriband Inc. (NASDAQ: NTRB) Featured on Smart Money Podcast
Nutriband (NASDAQ: NTRB) was recently featured on the Smart Money Circle Show, where Serguei Melnik, NTRB’s founder and president, unveiled his no-nonsense approach to biotech entrepreneurship. Standing in stark contrast to the conventional playbook are his grounded…
-
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Clears Regulatory Hurdle for 7.2 MW Hoadley Hill Solar Project in New York
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and…
-
BluSky AI Inc. (BSAI): Building the Infrastructure Behind the Intelligence
As generative AI sweeps across industries, from healthcare to marketing to national defense, one major problem threatens to stall progress: infrastructure. The computer power required to support artificial intelligence is exponentially higher than traditional internet…
-
MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Targets Multiple 2025–2026 Catalysts Across Rare Disease Pipeline
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, issued a shareholder update outlining key clinical and strategic milestones. President and CEO Dr. Christopher J. Schaber highlighted upcoming…
-
Safe Pro Group Inc. (NASDAQ: SPAI) Is ‘One to Watch’
Safe Pro Group (NASDAQ: SPAI) is a mission-driven technology company delivering advanced AI-powered security and defense solutions. It is focused on serving customers in the defense, homeland security, humanitarian, law enforcement, and commercial markets where its AI,…
-
MissionIRNewsBreaks – Why HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’
HeartBeam (NASDAQ: BEAT) is a medical technology company developing a groundbreaking solution for at-home detection and monitoring of cardiac conditions. “HeartBeam’s vision is to redefine cardiac care by enabling early detection, proactive monitoring, and informed clinical…
-
Safe Pro Group Inc. (NASDAQ: SPAI) Joins Russell Microcap(R) Index, Signaling Growing Investor Recognition, Market Visibility
Safe Pro Group (NASDAQ: SPAI), an emerging provider of AI-powered security and threat detection solutions, announced its addition to the Russell Microcap(R) Index, effective after market close on June 27, 2025. The inclusion comes as…
-
MissionIRNewsBreaks – BluSky AI Inc. (OTC: BSAI) Secures 9.3 MW Power and Land for Flagship Utah Data Center
BluSky AI (OTC: BSAI), a developer of modular AI data center infrastructure, announced the acquisition of its first operational site in Central, Utah, securing 9.3 MW of grid-connected power through an agreement with Digital Asset…
-
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly-owned subsidiary HOPE Therapeutics, Inc., a multi-site clinical care delivery organization, recently signed a binding letter of intent to acquire a 49% stake in Cohen…
-
Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025
Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple…
-
BlueSky AI Inc. (BSAI) Expands Market Presence with Strategic Milestones in AI Infrastructure
BlueSky AI (OTC: BSAI) has rapidly emerged as a key player in modular AI data center infrastructure, achieving major milestones in the past two years. The company has moved from concept to execution with its scalable…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Launches AI-Powered Touchless Neural Control Project for Military Use
- MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Subsidiary Starlight Therapeutics Cleared by FDA to Begin GBM Combination Trial
- MissionIRNewsBreaks – Alliance Entertainment (NASDAQ: AENT) Elevates Seven Key Leaders to Senior VP Roles
- MissionIRNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Offers $7,500 Price Cut on Mullen ONE and THREE EVs Ahead of Incentive Deadline
- MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Applauds FAA Proposal to Normalize BVLOS Drone Operations